Comparison Chart Bolt Biotherapeutics, Inc.
Stocks
BOLT
US0977022039
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 4.000 USD | -5.66% |
|
-2.68% | -26.85% |
| 08-11 | Bolt Biotherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 05-12 | Bolt Biotherapeutics reports first quarter 2026 financial results | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BOLT BIOTHERAPEUTICS, INC. | Bio Therapeutic Drugs | -5.66% | -2.68% | -26.85% | -30.44% | -98.52% | 7.71M |  |  |  |
- Stock Market
- Stocks
- BOLT Stock
- Charts Bolt Biotherapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
